Vector Laboratories, a leader in innovative proteomic and glycomic research solutions, and Navinci, an established developer of in situ proximity ligation assay-based solutions, today announced the ...

Novel multiomics tumor profiling demonstrates feasibility and clinical benefit in guiding melanoma treatment decisions, a study finds.